Table 2.
IV group (n = 146) | PO group (n = 98) | p value | |
---|---|---|---|
Community-acquired, n (%) | 127 (87.0) | 92 (93.9) | 0.08 |
Polymicrobial Blood Culture | 24 (16.4) | 11 (11.2) | 0.25 |
Source of bloodstream infection, n (%) | |||
Pneumonia | 26 (17.8) | 28 (28.6) | 0.06 |
Skin and soft tissue infections | 31 (21.2) | 14 (14.3) | 0.18 |
Intra-abdominal infections | 29 (19.9) | 11 (11.2) | 0.08 |
Urinary | 6 (4.0) | 7 (7.1) | 0.39 |
Ear–nose–throat infections | 5 (3.4) | 2 (2.0) | 0.71 |
Surgical manipulation | 2 (1.4) | 0 (0) | 0.52 |
Catheter-associated | 1 (0.7) | 1 (1.0) | >0.99 |
Other | 4 (2.7) | 14 (14.3) | <0.01 |
Unknown | 42 (28.8) | 21 (21.4) | 0.23 |
Microbiology, n (%) | |||
Viridans group streptococcus | 37 (25.3) | 22 (22.4) | 0.65 |
Streptococcus pneumoniae | 22 (15.1) | 25 (25.5) | 0.05 |
Streptococcus agalactiae (group B) | 27 (18.5) | 13 (13.3) | 0.30 |
Streptococcus pyogenes (group A) | 23 (15.8) | 17 (17.3) | 0.86 |
Streptococcus anginosus | 8 (5.5) | 9 (9.2) | 0.31 |
Streptococcus mitis/oralis | 10 (6.8) | 1 (1.0) | 0.05 |
Streptococcus gallolyticus | 6 (4.1) | 2 (2.0) | 0.48 |
Streptococcus constellatus | 2 (1.4) | 5 (5.1) | 0.12 |
Streptococcus, beta hemolytic (not group A, B, or D) | 4 (2.7) | 0 (0) | 0.15 |
IV, intravenous; PO, oral.